A Randomised, Double-Blind, Active-Controlled, Double-Dummy, Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Cancer Pain

Trial Profile

A Randomised, Double-Blind, Active-Controlled, Double-Dummy, Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Cancer Pain

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2014

At a glance

  • Drugs Oxycodone/naloxone (Primary) ; Oxycodone
  • Indications Cancer pain; Constipation
  • Focus Therapeutic Use
  • Acronyms CONFORT
  • Sponsors Mundipharma GmbH
  • Most Recent Events

    • 01 Jan 2012 Results published in Palliative Medicine.
    • 02 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Aug 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top